• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Effects on the STAT3-shRNA in Non-Small-Cell Lung Cancer Therapy:Design, Induction of Apoptosis, and Conjugation with Chitosan-Based Gene Vectors

    2021-08-30 06:14:10ZHANGWangwangZHANGYanJIANGZhiwenSUNLeWANGLitongGUZhiyangLIWenyaGUOLiliCHENXiaotongZHANGHaibinHANBaoqinandCHANGJing
    Journal of Ocean University of China 2021年5期

    ZHANG Wangwang, ZHANG Yan, JIANG Zhiwen, SUN Le, WANG Litong, GU Zhiyang, LI Wenya, GUO Lili, CHEN Xiaotong, ZHANG Haibin, HAN Baoqin, and CHANG Jing, *

    Effects on the STAT3-shRNA in Non-Small-Cell Lung Cancer Therapy:Design, Induction of Apoptosis, and Conjugation with Chitosan-Based Gene Vectors

    ZHANG Wangwang1), #, ZHANG Yan1), #, JIANG Zhiwen1), 2), SUN Le1), WANG Litong1), GU Zhiyang1), LI Wenya1), GUO Lili1), CHEN Xiaotong1), ZHANG Haibin1), HAN Baoqin1), 2), and CHANG Jing1), 2), *

    1),,266003,2),,266235,

    STAT3 plays a particularly important role in several cancer-related signal transduction pathways. Silencing STAT3RNA interference or small molecule inhibitors induces the apoptosis of tumor cells, thereby inhibiting the growth of the tumors. In this study, short-hairpin RNA sequences targeting the STAT3 genes were designed, synthesized, and then connected to pGPU6/GFP/Neo plasmids as the shRNA-expression vectors. The expression of STAT3-shRNA was analyzed by real-time PCR, western blotting, and cell apoptosis assay to study the growth and apoptosis of the cells. Then, the effect of STAT3 knockdown on the NCI-H1650 cells was studied in a tumor mouse model. The results revealed that, after antransfection, the proliferation of NCI-H1650 cells was inhibited, and the cells were induced to apoptosis. The mRNA and protein expression levels of STAT3 were downregulated in the STAT3-shRNA group., the tumor mass and volume in the STAT3-shRNA group were significantly lower than in the other two groups. Both theandresults demonstrated a long-period inhibiting effect on NSCLC, especially, when the tumor inhibition rate could reach 50% in the STAT3-shRNA group, which is an exciting outcome. Moreover, the study of the conjugation of STAT3-shRNA and chitosan-based vectors revealed that they could be combined steadily with good cytocompatibility and transfection efficiency. These results together provide convincing evidence for the application of STAT3-shRNA used in the treatment of non-small lung cancer, which could be a promoting prospect for the development of gene therapy.

    signal transducer and activator of transcription 3; short-hairpin RNA; target downregulation; chitosan-based vectors; gene therapy

    1 Introduction

    The overall 5-year survival rate of all lung cancer patients is approximately 14%, and most of them are diagnosed with non-small-cell lung cancer (NSCLC) (Steelman., 2004; Howard., 2005; Siegel., 2017).However, the methods of treatment are limited to surgery, radiotherapy, and chemotherapy (Sundar, 2014; Kot- mak??., 2017; Russo., 2017). Although chemotherapy has been reported to increase a patient’s lifespan, it kills healthy cells in the patient’s body, subsequently creating additional complications for the patients. Unfor- tunately, >70% of these patients are diagnosed with unresectable advanced tumors, and their immune functions are greatly reduced due to radiotherapy (Li., 2018).Since the metastasis of cancer cells has not been specifical- ly studied, the prevention and treatment of NSCLC is becoming increasingly difficult and needs to be urgently re- solved (Lin., 2017; Xi., 2017; Kim., 2018).

    In order to improve the treatment effect and avoid the resultant side-effects, gene therapy has been developed to target the transfers or restrictions in cancer cells (Uch., 2003), which can introduce hereditary materials into cells to activate a normal function or correct abnormal function by a virus or a non-virus vector. Thus, re- cognition molecules play a key role in cancer progression and promise to provide new therapeutic targets and reasons for lung cancer treatment (Grisch-Chan., 2017; Yu., 2018). To date, several NSCLC treatments using gene therapy have been studied. For example, the hsa- miR-124a-targeting USP14 has been shown to enhance NSCLC cells’ sensitivity to Gefitinib drug, and the miR- 9-5p has been reported to promote cell growth and metas- tasis in NSCLC by repressing TGFβR2 (Han., 2015).

    RNA interference (RNAi) has been demonstrated to be an influential tool for downregulating genes and re-sensitizing drug-resistant cancer cells. According to a past study on RNAi, more than 20 different drugs known as small- interfering RNAs (siRNAs) or short-hairpin RNAs (shRNAs)have been studied (Burnett., 2011; Ni., 2011). The mechanism of RNAi is the use of powerful polymerase III promoters to induce the expression of stem-loop shRNAs, and the dicer can make it into RNAi triggers (Brummelkamp., 2002; Paddison., 2002; Adams., 2017). shRNAs refers to RNA sequences with a hairpin loop structure that can overcome the shortcomings of the siRNA expression and can exert a relatively stronger effect of gene silencing than siRNA. This expression has excellent continuity and can last for several months. It is more suitable for gene function research and downregulation of the target genes underconditions (Aagaard and Rossi, 2007; Rao., 2009; Zhao., 2018).

    STAT3, a member of the signal transducer and activator of the transcription family, plays a critical role in a variety of cancer cells. STAT3 activation is conducive to induce the proliferation of tumor cells, thereby deteriorating cancer (Spitzner., 2014; Xu and Lu, 2014). The activation of STAT3 can also affect several other ma- lignancies, such as lymphomas, ovarian cancer, prostate cancer, and others (Scott and Gandhi, 2015). Inhibiting the STAT3 expression by RNAi or small molecule inhibitors can influence the proliferation, invasion, and apoptosis of tumor cells (Lin., 2015; Cho., 2016). The study in NSCLC determined that the downregulation of the STAT3 expression can inhibit tumor growth, revealing that the STAT3 may be a potential target for the treatment of NSCLC. Based on the understanding of thegene, RNAi can target the gene and inhibit the expression of genes through interfering signaling pathways related to the tumor, which in turn inhibit the metastasis of the tumor and leading to satisfying treatment of the tumor disease (Klink., 2012; Sun., 2013).

    The gene vectors are important vehicles to help shRNA enter the cells. It is well known that liposome and PEI 25k possess strong cytotoxicity (Feng., 2014), which can affect the normal physiological activities of cells in several ways, such as by participating in the regulation of the protein kinase C (PKC) pathway (Movassaghian., 2013), inhibiting the activity of ATPase (Jiang and Aliasger, 2012) and interacting with the mitochondrial membrane (Pinnapireddy., 2017). Therefore, it is necessary to select a safe and effective gene carrier. Chitosan (CTS) is a linear copolymer of β-1,4 linked N-acetyl-D- glucosamine (GlcNAc) and D-glucosamine (GlcN), and it is the only polysaccharide that carries positive charges (Hattori and Ishihara, 2015). Several CTS-based gene vec-tors have been reported to exhibit good biocompatibility, good biodegradability, and low toxicity (Oliveira and Silva, 2015). Herein, a new typeof CTS-based gene vector called vitamin E succinate-CTS-histidine (VCH) was fabricated to assists shRNAs when entering the cells.

    As depicted in Scheme 1, specific methods for RNAi were studied to downregulate the STAT3 expressionandin this study. The targeting gene sequences were synthesized, and the shRNA could enter the cells and associate with the nuclear region to influence the mRNA. Various indicators on the evaluation effect were explored to study the influence of shRNA on the apoptosis of lung cancer cells. Both the results ofandexperiments demonstrated a long-period inhibiting effect on NSCLC, especially the tumor inhibition rate could reach 50% in the STAT3-shRNA groupundercondition. The conjugation of STAT3-shRNA and CTS- based vectors were studied, and the results revealed that they could be combined steadily to demonstrate good cy- tocompatibility and transfection efficiency. The results can provide some experimental data for use in the treatment of lung cancer by gene therapy as well as provide evident ideas for the future study of different signal transduction pathways in an organism and their impact on cell proliferation and migration.

    2 Materials and Methods

    2.1 Materials

    CTS and the vitamin E succinate-CTS-histidine (VCH) were prepared and provided by our laboratory. Lipofecta- mine 2000 was purchased from Invitrogen. pGPU6/GFP/ Neo was purchased from Gene Pharma Co., Ltd. (Shanghai,China). PEI 25k, Hoechst 33258, and 3-(4,5-dime-thyl-thia- zol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were pur- chased from Sigma-Aldrich (USA). NCI-H1650 cells and A549 cells were cultured in RPMI 1640 medium supplemented with 10% FBS (Gibco?) in a humidified incubator at 37℃with 5% CO2. Goat anti-rabbit 1gG-HRP was purchased from Abcam (Cambridge, UK). Goat anti-mouse 1gG-HRP was purchased from Key GEN (Key GEN BioTECH, China). All other chemicals and reagents used in this study were of the highest commercial grade available.

    2.2 shRNA-Mediated Downregulation of STAT3

    STAT3-targeting and negative-control shRNAs were sourced from Gene Pharm Technologies (Shanghai, China). The sequences of STAT3-targeting and negative-control shRNAs are shown in Table 1. Stable culture ofDH5α was transformed with the plasmids (pGPU6/GFP/ Neo STAT3-shRNA) that encoded shRNA and targeted the mRNA of STAT3, and the plasmids (pGPU6/GFP/Neo scramble-shRNA) were obtained using the same method. H650 cells were transfected with STAT3 shRNA or scramble-shRNA at 85% confluence using Lipofectamine 2000. After 24h of incubation, the cells were checked for gene expression. The H1650 cells were transfected with STAT3 shRNA or scramble-shRNA and then selected with puro- mycin to form stable cell lines.

    Table 1 STAT3-targeting and negative control shRNAs

    2.3 Cell Transfection in vitro and the Effect on the Induction of Apoptosis

    2.3.1 Cell transfection

    The H1650 cells were plated in 6-well plates (1×105cellsperwell) and transfected with STAT3-shRNA or scramble-shRNA using Lipofectamine 2000 when the cultured H1650 cells were up to 85% confluence. The H1650 cells of the control group were incubated without transfection. After 24, 48, and 72h of incubation, the fluorescence of the three groups was assessed by confocal laser scanning microscopy (Nikon, Japan).

    2.3.2 Cell proliferation assay

    The cell proliferation was evaluated by the MTT assay, and the NCI-H1650 cells were seeded in 96-well culture plates (4×103cellsperwell) and allowed to attach for 24h. Next, the cells were transfected with STAT3-shRNA or scramble-shRNA. The cells were then cultured for an ad- ditional 24h or 48h after the transfection. These cells were incubated with MTT for 4h and then treated with dime- thyl sulfoxide. The absorbance of each well was analyzed at 492nm on the Multiskan Go 151 Microplate Scanning Spectrophotometer (Thermo Fisher Scientific, INC, USA). The cell relative viability (%) was finally calculated.

    2.3.3 Real-time PCR

    The H1650 cells were plated in 6-well plates and transfected with STAT3-shRNA or scramble-shRNA as descri- bed earlier. After incubation of 24 and 48h, the total RNA of the cells was extracted with Trizol (Takara, Dalian,China) following the manufacturer’s protocol. The reverse transcription was achieved using the Prime Script RT reagent kit (Takara). The primers used for STAT3 and the β-actin gene were as follows: STAT3 forward, 5’-GCTA CAGCAGCTTGACACACG-3’ and STAT3 reverse 5’-G TGGCATGTGATTCTTTGCTGGC-3’; β-actin forward, 5’- AGAAAATCTGGCACCACACC-3’ and β-actin reverse, 5’-TAGCACAGCCTGGATAGCAA-3’. β-actin was used as an endogenous control. The PCR setcycle conditions were 98℃ for 5min, 98℃ for 10s, 50℃ for 15s, 72℃ for30s, after which the relative STAT3 expression was esti- mated by qRT-PCR (Roche,Germany) and obtained based on the 2?ΔΔCtmethod (Schmittgen and Livak, 2008).

    2.3.4 Western blotting

    The cells transfected with STAT3-shRNA or scramble- shRNAs were cultured for an additional 48h. After the transfection, the proteins in the three groups were extracted with RIPA buffer. The different samples were assessed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Then, the membranes were incubated with different antibodies. The antibodies used were as fol- lows: rabbit anti-human STAT3 (1:600), mouse anti-human β-actin (1:200), goat anti-rabbit 1gG-HRP (1:1000), and goat anti-mouse 1gG-HRP (1:1000). At last, the protein bands of the three groups were visualized using DBA (Lunavat., 2016), and the bands were analyzed by the Image J software.

    2.3.5 Cell apoptosis assay

    The apoptosis of the H1650 cells was checked at 48h after treatment. First, the cells were added with Hoechst 33258 and left at room temperature for 10min in the dark and then photographed by laser confocal scanning microscope (Nikon). The images were randomly selected in each sample and reported as an average.

    2.3.6 Flow cytometry

    The cells were obtained using trypsin without EDTA to perform a single cell suspension. Then, the harvested cellswere treated by Annexin V-FITC/propidium iodide apoptosis detection kit (Key GEN Biotech, China) by flow cytometry (BD Biosciences). The cell apoptosis ratio was analyzed using the Cell Quest software (BD Biosciences). For the three groups of samples, the mean fluorescence intensity of 10000 cells was determined using the software FlowJo.

    2.4 Anti-Tumor Experiment in vivo and Histopathological Examination

    2.4.1 Anti-tumor experiment

    We purchased 20 BALB/c nude female mice (weight 18–22g) from the Vital River Laboratory Animal Technology Co., Ltd. (Beijing, China). The experimental mice were fed in a sterile laminar flow at the Qingdao University Animal Experimental Center. A total of 18 nude mice were randomly divided into three groups. Stable STAT3 knockdown or control H1650 cells were collected and su- spended with RPMI-1640 medium (without FBS). Then, the cells were injected into the flanks of BALB/c nude mice (1×107cellspermouse). The size of the tumor was measured every 3d by using a caliper, and the volume of tumors was calculated according to the following formula:=(length×width2)/2. After 28d, the tumor tissues were removed and weighed.

    2.4.2 Histopathological examination of the tumor samples

    The mice tumors were removed and weighed. The tumor tissues of the three groups were maintained in 4% paraformaldehyde solution. We excised the tumor tissues as a 5-μm section and performed HE staining to assess the tumor histology. The sections were then subjected to pho- tomicroscope observations. All photomicrographs for the three groups were taken with digital camera software.

    2.5 The Conjugation of STAT3-shRNA and CTS-Based Vectors

    2.5.1 Morphologies and agarose gel retardation assay

    The morphology of VCH was tested using TEM (JEOL JEM-100CX, Japan) and the zeta potential was immediately obtained by using the zeta sizer Nano ZS (Malvern, UK). The VCH and STAT3-shRNA plasmids were mixed according to different N/P ratios, and the gel retardation test was performed to determine the DNA binding ability of VCH. The complexes were mixed softly and then placedat 37℃ for 30min. Then, 10μL of different complexes pre- pared were electrophoresed on 1% (w/v) agarose gel at 80V for 70min.

    2.5.2 The cytotoxicity of the VCH/pDNA complexes

    The cytotoxicity of VCH/pDNA complexes was studied using the MTT assay. The L929 cells were seeded in 96-well plates at a density of 2×104cellscm?2and cultured in a 5% CO2incubator for 24h. The culture medium was discarded and added in DMEM (without FBS) at different concentrations of CTS-based materials and materials/pDNAcomplexes (N/P=55). After culturing for 24h and 48h, MTT assay was performed to quantify the viability of the cells.

    2.5.3transfection of VCH/pDNA

    The gene transfection efficiency of the VCH was eva- luatedwith A549 cells. The VCH/pDNA complexes and CTS/pDNA complexes were obtained at the N/P ratios of 45, 55, and 65, respectively. The A549 cells were added to 24-well plates (8×104cellsperwell) and then cultured under an atmosphere of 5% CO2for 24h. The VCH/ pDNA complexes containing 0.8μg pDNA were added to 24-well plates in DMEM without FBS. After 4h of cultivation, the complexes were removed and replaced with fresh DMEM, after which the well plates were incubated at 37℃ for another 48h. The results were obtained using a fluorescence microscope (Leica, Germany) and by using the flow cytometry method (FACE Vantage, BD, USA). Next, the relative STAT3 expression was assayed by qRT- PCR (Roche) using the method described in Section 2.3.3. The transfected HEK-293 cells with CTS and the transfected HEK-293 cells with PEI 25k served as negative and positive controls, respectively.

    2.6 Statistical Analyses

    The student’s t-test was used to determine whether the difference observed between the two groups was significant. All data were presented as the mean±standard deviation (SD) from at least 3 independent experiments.P <0.05 was considered to be statistically significant.

    3 Results

    3.1 Cell Transfection

    STAT3-targeting and negative-control shRNAs are successfully obtained. Subsequently, the H1650 cells were transfected with STAT3-shRNA and scramble-shRNA plasmids. The expression of plasmids in the cells was de- tected by confocal laser scanning microscopy (CLSM) at 24 and 48h, respectively. pGPU6/GFP/Neo possessed the gene of green fluorescent protein, such that the transfectedcells could be observed with green fluorescence. As shown in Fig.1, intense green fluorescence was detected in both the scramble-shRNA group and the STAT3-shRNA group. No significant difference was noted concerning morphological change or reduction in fluorescence between 24h and 48h of incubation in both the groups. However, the cells in the STAT3-shRNA group showed much less green fluorescence than the negative-control cells, indicating that the expression of STAT3-shRNA could affect the state of cells.

    Fig.1 Laser confocal scanning microscopy of H1650cells (scale bar: 100μm). (a), scramble-shRNA group; (b), STAT3- shRNA group. A, bright field; B, fluorescence field; C, merged field; 1, 24h; 2, 48h.

    3.2 Silencing of STAT3 Suppresses Cell Proliferation in H1650 Cells

    As shown in Fig.2(a), the cells in the control group exhibited a proper morphology without any apoptosis appearance. No significant change was noticed in the scram- ble-shRNA group and the control group. However, after 24h of incubation, evident apoptosis could be noted in the STAT3-shRNA group, such as cell shrinkage and the dis- appearance of ligation between the cells. After 72h of in- cubation, the apoptosis in the STAT3-shRNA group became more evident. When compared with that in the other two groups, the number of cell apoptosis in the STAT3- shRNA group was increased, and the basic cell morphology had disappeared.

    Fig.2 (a), microscope photographs of H1650 (100×). A, control group; B, scramble-shRNA group; C, STAT3-sh- RNA group; 1, 24h; 2, 48h; 3, 72h. (b), the relative growth rate of H1650. n=6, *P<0.05, **P<0.01, when compared with the control and the scramble-shRNA groups, respectively.

    As shown in Fig.2(b), the relative growth rate of the control group was >100%. The relative growth rate showed a slight decrease for the scramble-shRNA group than for the control group, possibly due to the toxicity of Lipofectamine 2000. However, the relative growth rate of the STAT3-shRNA group was reduced at 24h to reach appro- ximately 30% at 72h. These results showed that STAT3- shRNA could significantly inhibit the proliferation of NCI- H1650 cells.

    3.3 The mRNA and Protein Expression Levels of STAT3

    The qRT-PCR resultsin Fig.3(a) demonstrate that the gene expression of the STAT3 in the STAT3-shRNA group was significantly less than that of the control group and the scramble-shRNA group. The control group and the scramble-shRNA group showed no significant difference in their results. As shown in Fig.3(b), the results of western blotting demonstrated that the levels of STAT3 in the STAT3-shRNA group weresignificantly lower than inthe other two groups. These results suggested that STAT3- shRNA could cause STAT3 downregulation.

    Fig.3 (a), the detection of STAT3 mRNA levels via quantitative real-time PCR (**P<0.01 when compared with the control group and the scramble-shRNA group); (b), detecting the cell STAT3 levels by western blotting.

    3.4 Downregulation of STAT3 Induces the Apoptosis of H1650 Cells

    After 48h of incubation, the cells in the three groups were stained with a Hoechst 33258 dye solution. The fluorescence distribution of the cells in the control group and thescramble-shRNA group were relatively uniform (Fig.4(a)).The cells were found to be intact, with no apparent cell apop- tosis and a stable normal form. However, the STAT3- shRNA group exhibited a large number of strong nuclear fluorescence, nuclear fragmentation, marginalization, and other typical morphological changes indicative of apoptosis.

    Fig.4 (a), targeting STAT3 promotes cellular apoptosis in H1650 cells. A, control group; B, scramble-shRNA group; C,STAT3-shRNA group; 1, bright field; 2, fluorescence field. (b), the apoptosis rate of cells in every group; (c), flow cytometry pattern of H1650 cells.

    The cells of the three groups were then assessed by flowcytometry at 24 and 48h, respectively (results in Figs.4(b),(c)). The apoptosis rates of the STAT3-shRNA group cells (33% at 24h and 39% at 48h) were higher than those of the control group and scramble-shRNA group. The results cumulatively suggest that STAT3-shRNA can promote the apoptosis of H1650 cells.

    3.5 Downregulation of STAT3 Impairs Tumorigenesis of H1650 Cells in Nude Mice

    Finally, the effects of STAT3 downregulation underconditions were determined. The H1650 cells transfected with STAT3-shRNA or scramble-shRNA were injected into nude mice. Fig.5(a) demonstrates that the body- weight of each mouse was the same, indicating that the expression of STAT3-shRNA had no adverse effect on the bodyweight of nude mice. As shown in Fig.5(b), the tumor formation time was approximately 7d in the scramble- shRNA group and control group, but 12d in the STAT3- shRNA group. The daytime in the treatment group was significantly later than in the other two groups. Meanwhile, the trend of tumor growth in this group was relatively slow. The tumor volume (approximately 600mm3) before the final sacrifice was smaller than that of the control and scramble-shRNA groups. After sacrifice, the tumors in the nude mice were detached and weighed. As shown in Figs.5(c–d), the tumor weight of the STAT3- shRNA group was lower than that of the other two groups, and that the graft tumors from the STAT3-shRNA group grew significantly slowly when compared with those in the scramble-shRNA group and control group. The results cumulatively revealed that the expression of STAT3-sh- RNA could significantly inhibit the growth of lung cancer H1650 cells in nude mice and that the STAT3-shRNA group was statistically significant when compared with the other two groups (<0.05).

    Fig.5 (a), body weight changes in the three groups of nude mice; (b), the growth of xenograft tumor in the three groups; (c), the comparison of average tumor weight in the three groups (**P<0.01 when compared with the control and scramble-shRNA groups); (d), macroscopic photographs of the tumors in the three groups; (e), HE staining optical micrographs of tumor tissues (scale bar: 10mm). A, control group, B, scramble-shRNA group; C, STAT3-shRNA group.

    The tumors’ pathological changes in the three groups were further analyzed. Fig.5(e) displays the HE images in the three groups. The tumor cells of the control and scram- ble-shRNA groups were deeply stained and tightly arranged. However, the tumor cells of the STAT3-shRNA group were arranged sparsely, with local necrosis areas, and the nucleus was broken and dissolved.

    3.6 The Morphology, Zeta Potential, and pDNA Combined Ability of VCH

    Fig.6(a) presents the morphology of VCH, indicating that the shape of the particles was a regular sphere and the size was approximately 150nm. It is well known that the particles with the sizes 50 to a few 100nm are most likely to enter into the cells. The zeta potential of VCH is displayed in Fig.6(b), with the value +38.6mV. The positive charge makes it easier for VCH to bind to pDNA. The ability of VCH and CTS binding with the plasmids are displayed in Figs.6(c) and (d), respectively. These results together demonstrate that the VCH material could be fully bounded with the plasmids at the N/P ratio of 2 and that there was no significant difference between VCH and CTS.

    3.7 The Cytotoxicity of VCH/pDNA Complexes

    The cytotoxicity of VCH and VCH/pDNA complexes in the L929 cells was studied by MTT assay. As shown in Fig.7, when the concentration of the material was in the range of 10–100μgmL?1, the relative growth rate of L929 cells in each group was >85% at 24h, almost reaching > 100% in 48h. This result indicated that CTS-based gene vectors had good cell compatibility and showed better cell compatibility with the commercial Lipofectamine 2000 and PEI 25k. These results provide a basis for the deve- lopment of new and safe CTS-based non-viral vectors that can be used to develop different types of drug-delivery carriers.

    Fig.6 (a), the morphology and size distribution of VCH; (b), the zeta potential of VCH; (c), agarose gel electrophoresis of VCH/pDNA with different N/P values; (d), agarose gel electrophoresis of CTS/pDNA with different N/P values.

    Fig.7 (a), microscopic photographs of L929 cells after 24h of transfection; (b), microscopic photographs of L929 cells after 48h of transfection; (c), the relative growth rate of VCH and CTS groups at various concentrations in the L929 cells. The data are presented as mean±standard deviation (n=6).

    3.8 In vitro Transfection of STAT3-shRNA Plasmids Conjugated with VCH

    The fluorescence images of A549 cells transfected with STAT3-shRNA plasmids for 48h are exhibited in Fig.8(a). The VCH group showed obvious green fluorescence. The transfection efficiency of VCH and CTS increased with the N/P ratios, indicating the most obvious fluorescence with 55 N/P ratios. The cells of the four groups were detected by flow cytometry at 55 N/P ratios, and the results are shown in Fig.8(b). The fluorescence intensity of the VCH group was significantly higher than that of the CTS group, and it achieved a similar outcome to that of the PEI 25k group, indicating the satisfactory gene transfection efficiency of the VCH vector. Then, the relative STAT3 expression of each group with the 55 N/P ratios was stu- died by the qRT-PCR method. The results in Fig.8(c) con- firmed that the gene expression of STAT3 in the VCH group was significantly lower than that of the control group and the CTS group, reaching similar results to those of the PEI 25k group. All the results of thetransfection experiments revealed the high efficiency of STAT3-shRNA pDNA conjugated with VCH vector in gene transfection, thus providing a broad prospect for the application of STAT3-shRNA and VCH in gene therapy.

    4 Discussion

    It is already known that STAT3 plays an essential role in tumor progression and development and that STAT3 is overexpressed in NSCLC tissues. It has also been accepted that the inhibition of STAT3 signaling accounts for the suppression of tumor cell migration, invasion, and proliferation (Waldmann, 2017). In addition, as RNA in- terference can degrade specific mRNAs, it is used as a cancer molecular diagnostic and therapeutic method. The methods of RNA interference included chemically synthesized siRNAs and shRNA expressed by vectors. Although both siRNA and shRNA can silence specific m- RNAs, the mechanism is not precisely the same. Regardless of persistence or effectiveness, shRNA was superior to siRNA. It was also found that when using RNA interference treatment of viral hepatitis C, the inhibition of lu- ciferase expression could be up to 92.8% by shRNA (Mc- Caffrey., 2002). Past studies have shown that <1% ofthe siRNA double-stranded molecules were retained within the cells for 48h after the transfection. However, shRNA could be synthesized in the cells continuously (McAnuff., 2007). Furthermore, it has been shown that the knockdown of STAT3 with shRNA could potentially re- duce tumor propagation and migration, which is consistent with the results of the present study (Spitzner., 2012).

    Fig.8 (a), fluorescence images of the VCH/pDNA complexes at different N/P ratios of 45, 55, and 65; (b), flow cytometry results of fluorescence intensity of VCH/pDNA at N/P ratios of 55; (c), flow cytometry results of fluorescence intensity of VCH/pDNA at N/P ratios of 55; (d), the detection of STAT3 mRNA levels via quantitative real-time PCR (*P<0.05, **P<0.01). CTS, chitosan; VCH, vitamin E succinate-chitosan-histidine; PEI, polyethyleneimine; linear, MW 25000.

    Supporting this result, the knockdown of STAT3 in this study reduced the proliferation of H1650 cells by RNAi. Moreover, RNA interference was noted to degrade speci- fic mRNAs, making it a cancer molecular diagnostic and therapeutic method. First, the recombinant pGPU6/GFP/ Neo STAT3-shRNA plasmids were successfully constru- cted, which were dissected with BamH I and Pst I enzymes and further screened for positive clones. Then, the recom- binant plasmid was preliminarily identified by agarose electrophoresis, and, finally, further confirmed by DNA sequencing. The results showed that the designed inserted vector fragment was consistent with the sequencing results. LipofectamineTM2000 was used to transfect recombinant plasmids into H1650 cells. Laser confocal scanning microscope images indicated that the H1650 cells had a large amount of green fluorescence expression after trans- fection of the experimental group and the negative plasmid group, signifying that the transfection effect of the two groups was satisfied.

    Apoptosis, a phenomenon of programmed cell death, plays a key role in tumor control and therapy. Past studies have shown that STAT3 does not directly cause carcinogenesis and that STAT3 can be activated to enter the nucleus and combine with the DNA phase, thereby affecting the transcription and expression of downstream genes (Dorritie., 2014). The study of the relative growth rate of H1650 cells revealed that the cell proliferation observed in control and scramble-shRNA groups had a significant difference when compared with that in the STAT3-shRNA group.The apoptosis ratio increased in the STAT3-shRNA group with an increase of the incubation time, indicating the long-time inhibition effect of STAT3-shRNA. Hoechst33258 fluorescence staining and Annexin V-FITC/PI fluorescent double-staining kit were used to detect the apoptosis of cells, showing the evident apoptosis phenomenon in the STAT3-shRNA group. The results of cell observation by laser confocal microscopy showed that the expression of STAT3 was silenced by the transfection of STAT3-shRNA plasmid, such that a large number of cells with strong nuclear fluorescence and other obvious apoptosis phenomena could be observed. After 48h, the apoptosis rate of H1650 cells in the STAT3- shRNA group was 39%. The protein and RNA samples extracted from H1650 cells were treated for 48h with STAT3-shRNA and then subjected to western blotting and qRT-PCR. The results of gene silencingfurther suggested that the constructed STAT3-shRNA plasmids could significantly downregulate the expression of STAT3. In addition, STAT3-shRNA significantly downregulated the mRNA and protein expression of STAT3qRT-PCR and western blotting., all results of the STAT3-shRNA group indicated a significant downregulation of cell viability and proliferation ability, while cell apoptosis was significantly upregulated. These results are also related to the JAK/STAT3 signal transduction pathway to target gene transcription.

    Subsequently, the establishment of a tumor model of verified gene silencingwas launched. Makowiecki(2014) suggested the siRNA approach to persona- lized treatment of NSCLC. When compared to the report on the use of siRNA, only a select few studies on NSCLC have used the shRNA methods. In this study, the tumor weight in the STAT3-shRNA group was lower than in the other two groups, indicating that tumors in the STAT3- shRNA group had a less moderate proliferation activity. The growth of lung cancer H1650 cells in nude mice was further suppressed and the tumor inhibition rate could reach 50% in the STAT3-shRNA group,which was an exciting result. These results also demonstrated that STAT3-sh- RNA could achieve a good silencing effectand demonstrated a more satisfying anti-tumor outcome.

    Finally, the STAT3-shRNA plasmids were conjugated with VCH materials, and the gene transfection efficiency of the composites was studied in further detail. The sizes of the VCH particles were approximately 150nm and the particles carried obvious positive charges. These 2 main properties of VCH could facilitate it to bind well with plasmids and assist the plasmids in entering into cells. The ability to combine with naked DNA was essential to use VCH as a gene vector, and the agarose gel retardation demonstrated that the VCH material could be bounded fully with the plasmids at the N/P ratio of 2. The VCH/ pDNA composites revealed good cytocompatibility; this feature could overcome the shortcomings of other gene vectors, such as Lipofectamine 2000 and PEI 25k, indicating severe cytotoxicity during the process of gene transfection. The transfection efficiency of VCH/pDNAwas studied by fluorescent observation, flow cytometry, and qRT-PCR methods. The cumulative results validated the consistent conclusions that the STAT3-shRNA pDNA conjugated with VCH had a high efficiency in gene transfection, which implies a promising future for the STAT3- shRNA application in gene therapy.

    5 Conclusions

    In conclusion, our experimental results demonstrated that pGPU6/GFP/Neo STAT3-shRNA could effectively downregulate STAT3 in H1650 cells and promote it to apoptosis, thereby inhibiting the proliferation of H1650 cells bothand. The CTS-based gene vector could facilitate theSTAT3-shRNA to enter into cells with successful transfection. These results suggest a therapeutic potential of STAT3 in the treatment of poor prognosis cases of NSCLC and lay a good foundation for further gene therapy for lung cancer treatment.

    Acknowledgements

    The authors wish to thank the National Natural Science Foundation of China (No. 51773188), the Natural Science Foundation of Shandong Province (No. ZR2017MC072), the National Key Research and Development Program (No. 2018YFC1105602), the Key Research and Development Program of Shandong Province (No. 2016YYSP018), the Second Maker Program of Marine Biomedical Research Institute of Qingdao (No. MGTD20170002M), the Scientific and Technological Innovation Project Financially Sup- ported by Qingdao National Laboratory for Marine Science and Technology (No. 2015ASKJ02).

    Aagaard, L., and Rossi, J. J., 2007. RNAi therapeutics: Principles, prospects andchallenges., 59(2-3): 75-86, DOI: 10.1016/j.addr.2007.03.005.

    Adams, F. F., Heckl, D., Hoffmann, T., Talbot, S. R., Kloos, A., Thol, F.,., 2017. An optimized lentiviral vector system for conditional RNAi and efficient cloning of microRNA embed- ded short hairpin RNA libraries., 139: 102-115, DOI: 10.1016/j.biomaterials.2017.05.032.

    Brummelkamp, T. R., Bernards, R., and Agami, R., 2002. A sys- tem for stable expression of short interfering RNAs in mammalian cells., 296 (5567): 550-553, DOI: 10.1126/sci ence.1068999.

    Burnett, J. C., Rossi, J. J., and Tiemann, K., 2011. Current pro- gress of siRNA/shRNA therapeutics in clinical trials., 6 (9): 1130-1146, DOI: 10.1002/biot.2011 00054.

    Cho, C. Y., Huang, J. S., Shiah, S. G., Chung, S. Y., Lay, J. D., Yang, Y. Y.,., 2016. Negative feedback regulation of AXL by miR-34a modulates apoptosis in lung cancer cells., 22 (2): 303-315, DOI: 10.1261/rna.052571.115.

    Dorritie, K. A., Redner, R. L., and Johnson, D. E., 2014. STAT transcription factors in normal and cancer stem cells., 56: 30-44, DOI: 10.1016/j.jbior. 2014.05.004.

    Feng, L., Xie, A., Hu, X., and Dong, W., 2014. A releasable di- sulfide carbonate linker for polyethyleneimine (PEI)-based gene vectors., 38 (11): 5207-5214, DOI: 10.1039/c4nj00699b.

    Grisch-Chan, H. M., Schlegel, A., Scherer, T., Allegri, G., Hei- delberger, R., Tsikrika, P.,., 2017. Low-dose gene therapy for murine PKU using episomal naked DNA vectors expressing PAH from its endogenous liver promoter.–, 7: 339-349, DOI: 10.1016/j.omtn.20 17.04.013.

    Han, Y., Jia, C., Cong, X., Yu, F., Cai, H., Fang, S.,., 2015. Increased expression of TGF βR2 is associated with the cli- nical outcome of non-small cell lung cancer patients treated with chemotherapy., 10 (8): 1-12, DOI: 10.1371/ journal.pone.0134682.

    Hattori, H., and Ishihara, M., 2015. Changes in blood aggregation with differences in molecular weight and degree of deacetylation of chitosan., 10 (1): 015014, DOI: 10.1088/1748-6041/10/1/015014.

    Howard, B. A., Furumai, R., Campa, M. J., Rabbani, Z. N., Vujaskovic, Z., Wang, X. F.,., 2005. Stable RNA interference-mediated suppression of cyclophilin A diminishes non- small-cell lung tumor growth., 65 (19): 8853-8860, DOI: 10.1158/0008-5472.

    Jiang, D. H., and Aliasger, K. S., 2012. Optimized dextran-po- lyethylenimine conjugates are efficient non-viral vectors withreduced cytotoxicity when used in serum containing environ- ments., 427 (1): 71- 79, DOI: 10.1016/j.ijpharm.2011.10.032.

    Kim, Y. S., Jin, H. O., Hong, S. E., Song, J. Y., Hwang, C. S., and Park, I. C., 2018. Silencing of secretory clusterin sensitizes NSCLC cells to V-ATPase inhibitors by downregulating survivin., 495 (2): 2004-2009, DOI: 10.1016/j.bbrc.2017.12.077.

    Klink, M., Kielbik, M., Nowak, M., Bednarska, K., and Sulowska, Z., 2012. JAK3, STAT3 and CD3-zeta signaling proteins status in regard to the lymphocytes function in patients with ovarian cancer., 41 (4): 382- 398, DOI: 10.3109/08820139.2011.640376.

    Kotmak??, M., ?etinta?, V. B., and Kantarc?, A. G., 2017. Pre- paration and characterization of lipid nanoparticle/pDNA com- plexes for STAT3 downregulation and overcoming chemotherapy resistance in lung cancer cells., 525 (1): 101-111, DOI: 10.1016/j.ijpharm.20 17.04.034.

    Li, R. Z., Fan, X. X., Duan, F. G., Jiang, Z. B., Pan, H. D., Luo, L. X.,., 2018. Proscillaridin A induces apoptosis and suppresses non-small-cell lung cancer tumor growthcalcium- induced DR4 upregulation., 9 (6): 1-14, DOI: 10.1038/s41419-018-0733-4.

    Lin, X., Li, H. R., Lin, X. F., Yu, M. E., Tu, X. W., Hua, Z. D.,., 2015. Silencing of Livin inhibits tumorigenesis and me- tastasisVEGF and MMPs pathway in lung cancer., 47 (2): 657-667, DOI: 10.3892/ ijo.2015.3058.

    Lin, X., Lin, B. W., Chen, X. L., Zhang, B. L., Xiao, X. J., Shi, J. S.,., 2017. PAI-1/PIAS3/Stat3/miR-34a forms a positive feedback loop to promote EMT-mediated metastasis through Stat3 signaling in non-small cell lung cancer., 493 (4): 1464-1470, DOI: 10.1016/j.bbrc.2017.10.014.

    Lunavat, T. R., Jang, S. C., Nilsson, L., Park, H. T., Repiska, G., L?sser, C.,., 2016. RNAi delivery by exosome-mimetic nanovesicles–Implications for targeting c-Myc in cancer., 102: 231-238, DOI: 10.1016/j.biomaterials.2016.06. 024.

    Makowiecki, C., Nolte, A., Sutaj, B., Keller, T., Avci-Adali, M., Stoll, H.,., 2014. New basic approach to treat non-small cell lung cancer based on RNA-interference.,5 (2): 112-120, DOI: 10.1111/1759-7714.12065.

    McAnuff, M. A., Rettig, G. R., and Rice, K. G., 2007. Potency of siRNAshRNA mediated knockdown., 96 (11): 2922-2930, DOI: 10. 1002/jps.20968.

    McCaffrey, A. P., Meuse, L., Pham, T. T. T., Conklin, D. S., Hannon, G. J., and Kay, M. A., 2002. RNA interference in adult mice., 418 (6893): 38-39, DOI: 10.1038/418038a.

    Movassaghian, S., Moghimi, H. R., Shirazi, F. H., Koshkaryev, A., Trivedi, M. S., and Torchilin, V. P., 2013. Efficient down- regulation of PKC-gene expression in A549 lung cancer cells mediated by antisense oligodeoxynucleotides in dendro- somes., 441 (1-2): 82- 91, DOI: 10.1016/j.ijpharm.2012.12.015.

    Ni, J. Q., Zhou, R., Czech, B., Liu, L. P., Holderbaum, L., Yang- Zhou, D.,., 2011. A genome-scale shRNA resource for transgenic RNAi in., 8 (5): 405- 407, DOI: 10.1038/nmeth.1592.

    Oliveira, A. V., and Silva, G. A., 2015. Chitosan-based vectors mediate long-term gene expression in the retina., 9 (5): 373-382, DOI: 10.1166/jbns.2015.1314.

    Paddison, P. J., Caudy, A. A., and Hannon, G. J., 2002. Stable suppression of gene expression by RNAi in mammalian cells., 99 (3): 1443- 1448, DOI: 10.1073/pnas.032652399.

    Pinnapireddy, S. R., Duse, L., Strehlow, B., Sch?fer, J., and Bakowsky, U., 2017. Composite liposome-PEI/nucleic acid lipo- polyplexes for safe and efficient gene delivery and gene knock- down., 158: 93-101.

    Rao, D. D., Vorhies, J. S., Senzer, N., and Nemunaitis, J., 2009. siRNA. shRNA: Similarities and differences., 61 (9): 746-759, DOI: 10.1016/j.addr.2009. 04.004.

    Russo, A. E., Priolo, D., Antonelli, G., Libra, M., McCubrey, J. A., and Ferrau, F., 2017. Bevacizumab in the treatment of NSCLC: Patient selection and perspectives., 8: 259-269, DOI: 10.2147/LCTT.S110306.

    Schmittgen, T. D., and Livak, K. J., 2008. Analyzing real-time PCR data by the comparative CTmethod., 3 (6): 1101, DOI: 10.1038/nprot.2008.73.

    Scott, L. M., and Gandhi, M. K., 2015. Deregulated JAK/STAT signalling in lymphomagenesis, and its implications for the development of new targeted therapies., 29 (6): 405-415, DOI: 10.1016/j.blre.2015.06.002.

    Siegel, R. L., Miller, K. D., Fedewa, S. A., Ahnen, D. J., Meester,R. G., Barzi, A.,., 2017. Colorectal cancer statistics, 2017., 67 (3): 177-193, DOI: 10.3322/caac.21332.

    Spitzner, M., Ebner, R., Wolff, H. A., Ghadimi, B. M., Wienands, J., and Grade, M., 2014. STAT3: A novel molecular mediator of resistance to chemoradiotherapy., 6 (4): 1986-2011, DOI: 10.3390/cancers6041986.

    Spitzner, M., Roesler, B., Bielfeld, C., Gaedcke, J., Rave-Fr?nk, M., Bei?barth, T.,., 2012. Stat3 is a potential molecular target for chemoradiosensitization of colorectal cancer cells.,72 (8): 3446-3446, DOI: 10.1158/1538-7445. AM2012-3446.

    Steelman, L. S., Pohnert, S. C., Shelton, J. G., Franklin, R. A., Bertrand, F. E., and McCubrey, J. A., 2004. JAK/STAT, Raf/ MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progressionand leukemogenesis., 18 (2): 189-218, DOI: 10.1038/ sj.leu.2403241.

    Sun, X., Sui, Q., Zhang, C., Tian, Z., and Zhang, J., 2013. Targeting blockage of STAT3 in hepatocellular carcinoma cells augments NK cell functionsreverse hepatocellular carcinoma-induced immune suppression., 12 (12): 2885-2896, DOI: 10.1158/1535-7163.

    Sundar, R., Soong, R., Cho, B. C., Brahmer, J. R., and Soo, R. A., 2014. Immunotherapy in the treatment of non-small cell lung cancer., 85 (2): 101-109, DOI: 10.1016/j. lungcan.2014.05.005.

    Uch, R., Gérolami, R., Faivre, J., Hardwigsen, J., Mathieu, S., Mannoni, P.,., 2003. Hepatoma cell-specific ganciclovir- mediated toxicity of a lentivirally transduced HSV-TkEGFP fusion protein gene placed under the control of rat alpha-fe- toprotein gene regulatory sequences., 10 (9): 689-695, DOI: 10.1038/sj.cgt.7700621.

    Waldmann, T. A., 2017. JAK/STAT pathway directed therapy of T-cell leukemia/lymphoma: Inspired by functional and structural genomics., 451: 66-70, DOI: 10.1016/j.mce.2017.02.019.

    Xi, K. X., Wen, Y. S., Zhu, C. M., Yu, X. Y., Qin, R. Q., and Zhang, X. W., 2017. Tumor-stroma ratio (TSR) in non-small cell lung cancer (NSCLC) patients after lung resection is a prognostic factor for survival., 9 (10): 4017-4026, DOI: 10.21037/jtd.2017.09.29.

    Xu, Y. H., and Lu, S., 2014. A meta-analysis of STAT3 and pho- spho-STAT3 expression and survival of patients with non- small-cell lung cancer., 40 (3): 311-317, DOI: 10.1016/j.ejso.2013.11.012.

    Yu, F., Liu, J. B., Wu, Z. J., Xie, W. T., Zhong, X. J., Hou, L. K.,., 2018. Tumor suppressive microRNA-124a inhibits stemness and enhances gefitinib sensitivity of non-small cell lung cancer cells by targeting ubiquitin-specific protease 14., 427: 74-84, DOI: 10.1016/j.canlet.2018.04.022.

    Zhao, G., Huang, Q., Wang, F., Zhang, X., Hu, J., Yan, Y.,., 2018. Targeted shRNA-loaded liposome complex combined with focused ultrasound for blood brain barrier disruption and suppressing glioma growth., 418: 147-158, DOI:10.1016/j.canlet.2018.01.035.

    #The two authors contributed equally to the work.

    . E-mail: jingchouc@163.com

    July 30, 2020;

    September 23, 2020;

    November 4, 2020

    ? Ocean University of China, Science Press and Springer-Verlag GmbH Germany 2021

    (Edited by Chen Wenwen)

    日韩欧美一区二区三区在线观看| 一本精品99久久精品77| 欧美乱码精品一区二区三区| 成人av一区二区三区在线看| 国产精品九九99| 1024视频免费在线观看| 精品久久蜜臀av无| 老司机福利观看| 欧美成狂野欧美在线观看| 悠悠久久av| 亚洲一区中文字幕在线| 一边摸一边做爽爽视频免费| 全区人妻精品视频| av免费在线观看网站| 国产精品免费视频内射| 国产99白浆流出| 一区二区三区高清视频在线| 国内少妇人妻偷人精品xxx网站 | 在线观看www视频免费| 久久久久久人人人人人| 波多野结衣高清无吗| 国产精品久久久av美女十八| 男女做爰动态图高潮gif福利片| 国产精品日韩av在线免费观看| 精品欧美国产一区二区三| 中文在线观看免费www的网站 | 亚洲色图 男人天堂 中文字幕| 级片在线观看| 免费在线观看影片大全网站| 国产亚洲欧美在线一区二区| 国产麻豆成人av免费视频| 日韩大尺度精品在线看网址| 大型黄色视频在线免费观看| 听说在线观看完整版免费高清| bbb黄色大片| 国产99久久九九免费精品| 夜夜看夜夜爽夜夜摸| 久久婷婷人人爽人人干人人爱| av视频在线观看入口| 少妇的丰满在线观看| 国产亚洲精品av在线| 国产三级中文精品| 久久中文字幕一级| 国产激情久久老熟女| 少妇熟女aⅴ在线视频| 亚洲欧美日韩无卡精品| 男女视频在线观看网站免费 | 在线免费观看的www视频| 色精品久久人妻99蜜桃| 91大片在线观看| 一边摸一边做爽爽视频免费| 99在线人妻在线中文字幕| 欧美成狂野欧美在线观看| 日本一本二区三区精品| 成人国产一区最新在线观看| 90打野战视频偷拍视频| 欧美黄色淫秽网站| 天天一区二区日本电影三级| 黄色女人牲交| 国产精华一区二区三区| 日日爽夜夜爽网站| 色在线成人网| av超薄肉色丝袜交足视频| 校园春色视频在线观看| 全区人妻精品视频| av有码第一页| 欧美中文日本在线观看视频| 国产精品一区二区精品视频观看| 亚洲成人国产一区在线观看| 制服诱惑二区| 啦啦啦观看免费观看视频高清| 亚洲一区二区三区色噜噜| 天堂√8在线中文| 最近最新免费中文字幕在线| 午夜久久久久精精品| 中文亚洲av片在线观看爽| 国产欧美日韩一区二区三| 免费看十八禁软件| 成人欧美大片| 午夜影院日韩av| 少妇裸体淫交视频免费看高清 | 国产精品综合久久久久久久免费| 听说在线观看完整版免费高清| 国产区一区二久久| 国语自产精品视频在线第100页| avwww免费| 母亲3免费完整高清在线观看| 国产精品永久免费网站| 老司机靠b影院| 床上黄色一级片| 男插女下体视频免费在线播放| 制服人妻中文乱码| 大型黄色视频在线免费观看| 日本免费a在线| 精品欧美一区二区三区在线| 三级男女做爰猛烈吃奶摸视频| 日韩欧美一区二区三区在线观看| 操出白浆在线播放| 99国产精品一区二区三区| 五月伊人婷婷丁香| 男人的好看免费观看在线视频 | 久久人妻福利社区极品人妻图片| 特大巨黑吊av在线直播| 动漫黄色视频在线观看| videosex国产| 老司机福利观看| 国产精品免费视频内射| 欧美日韩中文字幕国产精品一区二区三区| av福利片在线| 91在线观看av| 少妇人妻一区二区三区视频| 亚洲av日韩精品久久久久久密| 男人舔奶头视频| 亚洲精品一卡2卡三卡4卡5卡| 成人特级黄色片久久久久久久| 黄色 视频免费看| 婷婷六月久久综合丁香| 欧美日韩中文字幕国产精品一区二区三区| 极品教师在线免费播放| 久久天躁狠狠躁夜夜2o2o| 成人手机av| 婷婷丁香在线五月| 中文字幕久久专区| 国产精品一区二区三区四区免费观看 | 俄罗斯特黄特色一大片| 丝袜人妻中文字幕| 精品熟女少妇八av免费久了| 亚洲avbb在线观看| 天堂av国产一区二区熟女人妻 | 亚洲精品色激情综合| 男女之事视频高清在线观看| 国产av又大| 757午夜福利合集在线观看| 午夜亚洲福利在线播放| 给我免费播放毛片高清在线观看| 狂野欧美白嫩少妇大欣赏| 亚洲天堂国产精品一区在线| 亚洲午夜理论影院| 亚洲人成网站在线播放欧美日韩| 国产av在哪里看| 99热只有精品国产| 精品国产乱码久久久久久男人| 亚洲色图 男人天堂 中文字幕| 国产精品 欧美亚洲| 欧美乱色亚洲激情| 欧美+亚洲+日韩+国产| 亚洲成人国产一区在线观看| 久久亚洲真实| √禁漫天堂资源中文www| 曰老女人黄片| 啦啦啦免费观看视频1| а√天堂www在线а√下载| 天堂影院成人在线观看| 男女午夜视频在线观看| 老鸭窝网址在线观看| 亚洲欧美日韩高清在线视频| 搡老岳熟女国产| 麻豆av在线久日| 高潮久久久久久久久久久不卡| 日韩欧美国产一区二区入口| 18禁裸乳无遮挡免费网站照片| 欧美最黄视频在线播放免费| av在线播放免费不卡| a在线观看视频网站| 窝窝影院91人妻| 日韩成人在线观看一区二区三区| 制服诱惑二区| 国产成+人综合+亚洲专区| 欧美黑人精品巨大| 好男人在线观看高清免费视频| 搡老熟女国产l中国老女人| av欧美777| 制服诱惑二区| 国产乱人伦免费视频| 亚洲精品美女久久久久99蜜臀| xxxwww97欧美| 我的老师免费观看完整版| 制服丝袜大香蕉在线| 久久久久精品国产欧美久久久| 悠悠久久av| 一夜夜www| 观看免费一级毛片| 成人三级黄色视频| 在线观看免费午夜福利视频| 国产精品99久久99久久久不卡| 亚洲国产欧洲综合997久久,| 亚洲精品国产一区二区精华液| 亚洲电影在线观看av| 听说在线观看完整版免费高清| 国产精品永久免费网站| 色在线成人网| 欧美日韩福利视频一区二区| 久久久久国产精品人妻aⅴ院| 岛国视频午夜一区免费看| 成年免费大片在线观看| 在线观看www视频免费| 叶爱在线成人免费视频播放| 高潮久久久久久久久久久不卡| 在线播放国产精品三级| 神马国产精品三级电影在线观看 | 91九色精品人成在线观看| 婷婷六月久久综合丁香| 成年免费大片在线观看| 亚洲成人久久性| 亚洲av第一区精品v没综合| 精品一区二区三区av网在线观看| 男人舔女人下体高潮全视频| 亚洲人与动物交配视频| 久久精品91蜜桃| 91av网站免费观看| 脱女人内裤的视频| 一进一出好大好爽视频| 中出人妻视频一区二区| 久久久久亚洲av毛片大全| 日本 欧美在线| 啦啦啦观看免费观看视频高清| 亚洲乱码一区二区免费版| 18美女黄网站色大片免费观看| 一区二区三区国产精品乱码| 美女黄网站色视频| 亚洲精品国产一区二区精华液| 老熟妇仑乱视频hdxx| 亚洲精品中文字幕一二三四区| 久久久久久久久免费视频了| 美女午夜性视频免费| 亚洲一卡2卡3卡4卡5卡精品中文| 国产精品1区2区在线观看.| 欧美日韩中文字幕国产精品一区二区三区| 久久国产精品人妻蜜桃| 无遮挡黄片免费观看| 午夜福利视频1000在线观看| 白带黄色成豆腐渣| 精品国产乱码久久久久久男人| 亚洲av成人精品一区久久| 国产在线观看jvid| 美女 人体艺术 gogo| 久久国产精品影院| 日韩欧美免费精品| 麻豆一二三区av精品| 久久亚洲精品不卡| 精品欧美一区二区三区在线| 亚洲真实伦在线观看| 黄片大片在线免费观看| 亚洲精品一卡2卡三卡4卡5卡| 精品久久久久久久毛片微露脸| 国产片内射在线| av天堂在线播放| 高清毛片免费观看视频网站| 色老头精品视频在线观看| 九色成人免费人妻av| 国产精品久久电影中文字幕| 国产野战对白在线观看| 日本一区二区免费在线视频| 午夜日韩欧美国产| 国产三级中文精品| 动漫黄色视频在线观看| 亚洲精品色激情综合| 好男人在线观看高清免费视频| 欧美最黄视频在线播放免费| 亚洲 国产 在线| or卡值多少钱| 亚洲avbb在线观看| 一级黄色大片毛片| 欧美黄色片欧美黄色片| 日本一二三区视频观看| 亚洲av成人精品一区久久| 动漫黄色视频在线观看| 午夜免费观看网址| 69av精品久久久久久| 成熟少妇高潮喷水视频| 手机成人av网站| av欧美777| 丝袜人妻中文字幕| www.精华液| 亚洲成人免费电影在线观看| 免费av毛片视频| 俺也久久电影网| 一本精品99久久精品77| 日韩中文字幕欧美一区二区| 五月玫瑰六月丁香| 亚洲人成伊人成综合网2020| 精品国产乱子伦一区二区三区| 国产v大片淫在线免费观看| 超碰成人久久| 久久精品夜夜夜夜夜久久蜜豆 | 国产成人影院久久av| svipshipincom国产片| 一级黄色大片毛片| 欧美黑人欧美精品刺激| 最近在线观看免费完整版| 国产在线精品亚洲第一网站| 亚洲精品中文字幕在线视频| 欧美黑人欧美精品刺激| 黄色片一级片一级黄色片| 在线观看舔阴道视频| 一级a爱片免费观看的视频| 1024视频免费在线观看| 免费在线观看日本一区| 成人国产一区最新在线观看| 91av网站免费观看| 欧美黄色淫秽网站| 夜夜看夜夜爽夜夜摸| 琪琪午夜伦伦电影理论片6080| 欧美久久黑人一区二区| 99热只有精品国产| 男女那种视频在线观看| 美女黄网站色视频| 九色国产91popny在线| 亚洲美女视频黄频| 法律面前人人平等表现在哪些方面| 国产野战对白在线观看| 欧美黄色淫秽网站| 精品久久久久久,| 可以在线观看的亚洲视频| 精品一区二区三区视频在线观看免费| 亚洲aⅴ乱码一区二区在线播放 | 欧美乱妇无乱码| 免费无遮挡裸体视频| 俄罗斯特黄特色一大片| 国产精品亚洲美女久久久| 变态另类丝袜制服| 国产av麻豆久久久久久久| 男女床上黄色一级片免费看| 国产成人av激情在线播放| 国产私拍福利视频在线观看| 国产精品 欧美亚洲| av国产免费在线观看| 亚洲免费av在线视频| 天天躁夜夜躁狠狠躁躁| 中文字幕精品亚洲无线码一区| 日韩欧美 国产精品| 丝袜人妻中文字幕| 一区二区三区激情视频| 男插女下体视频免费在线播放| 国产精品1区2区在线观看.| 69av精品久久久久久| 超碰成人久久| 99国产精品一区二区蜜桃av| 欧美不卡视频在线免费观看 | 一区二区三区激情视频| 亚洲成av人片免费观看| 女同久久另类99精品国产91| 午夜福利在线观看吧| 777久久人妻少妇嫩草av网站| 一夜夜www| 国产精品亚洲美女久久久| 国产精品自产拍在线观看55亚洲| 好看av亚洲va欧美ⅴa在| 嫩草影院精品99| 男男h啪啪无遮挡| av有码第一页| 9191精品国产免费久久| 久久中文字幕人妻熟女| 亚洲一区二区三区不卡视频| 香蕉丝袜av| 国产亚洲精品综合一区在线观看 | 国产真实乱freesex| 麻豆成人av在线观看| a级毛片在线看网站| 岛国在线观看网站| 亚洲aⅴ乱码一区二区在线播放 | 欧美日韩一级在线毛片| 亚洲专区中文字幕在线| aaaaa片日本免费| 成人国产一区最新在线观看| 欧美色欧美亚洲另类二区| 久久久久亚洲av毛片大全| 国产成人aa在线观看| 12—13女人毛片做爰片一| 欧美成狂野欧美在线观看| 国产99白浆流出| 久久午夜亚洲精品久久| 成人av一区二区三区在线看| 午夜老司机福利片| 亚洲真实伦在线观看| av片东京热男人的天堂| av国产免费在线观看| 婷婷丁香在线五月| 久久婷婷人人爽人人干人人爱| 国产精品 欧美亚洲| 美女大奶头视频| 欧美成人免费av一区二区三区| www日本黄色视频网| 欧美极品一区二区三区四区| 久久精品aⅴ一区二区三区四区| 欧美日韩亚洲国产一区二区在线观看| 国产蜜桃级精品一区二区三区| 午夜成年电影在线免费观看| 国产蜜桃级精品一区二区三区| 高清在线国产一区| 亚洲,欧美精品.| 99热这里只有是精品50| 亚洲精品国产精品久久久不卡| 丁香六月欧美| 久久久久久国产a免费观看| 中文字幕高清在线视频| 日本免费a在线| 757午夜福利合集在线观看| 国产精品久久久久久人妻精品电影| 亚洲一区中文字幕在线| 18禁裸乳无遮挡免费网站照片| 日本黄色视频三级网站网址| 麻豆国产av国片精品| 99久久久亚洲精品蜜臀av| 亚洲一卡2卡3卡4卡5卡精品中文| 国产精品影院久久| 精品午夜福利视频在线观看一区| 色在线成人网| 中文字幕精品亚洲无线码一区| 两个人的视频大全免费| 免费在线观看亚洲国产| 天天躁夜夜躁狠狠躁躁| 俺也久久电影网| 午夜两性在线视频| 亚洲一卡2卡3卡4卡5卡精品中文| 国产av在哪里看| 老司机午夜福利在线观看视频| 国产又色又爽无遮挡免费看| 久久午夜综合久久蜜桃| 哪里可以看免费的av片| 国产熟女xx| 黄频高清免费视频| 久热爱精品视频在线9| 男插女下体视频免费在线播放| 久久婷婷成人综合色麻豆| 国产精品美女特级片免费视频播放器 | 国产精品精品国产色婷婷| 成人精品一区二区免费| 久久中文字幕人妻熟女| 欧美日韩精品网址| 丝袜人妻中文字幕| 国产爱豆传媒在线观看 | 国产在线观看jvid| 国内精品久久久久久久电影| 999精品在线视频| 身体一侧抽搐| 日本免费a在线| 欧美日本视频| 十八禁网站免费在线| 法律面前人人平等表现在哪些方面| 亚洲成人精品中文字幕电影| 亚洲一区高清亚洲精品| 伊人久久大香线蕉亚洲五| 久99久视频精品免费| 每晚都被弄得嗷嗷叫到高潮| 99riav亚洲国产免费| 黑人巨大精品欧美一区二区mp4| 一个人免费在线观看电影 | 欧美极品一区二区三区四区| 好男人电影高清在线观看| 99riav亚洲国产免费| 曰老女人黄片| 制服丝袜大香蕉在线| 在线国产一区二区在线| 亚洲av成人av| 最新美女视频免费是黄的| 亚洲片人在线观看| 国产成人欧美在线观看| 婷婷精品国产亚洲av在线| 国产精品美女特级片免费视频播放器 | 夜夜夜夜夜久久久久| 亚洲全国av大片| 制服诱惑二区| 变态另类成人亚洲欧美熟女| 99国产精品一区二区蜜桃av| 欧美 亚洲 国产 日韩一| 俄罗斯特黄特色一大片| 久久久久久久久中文| 亚洲av成人av| 99热这里只有是精品50| 久久精品aⅴ一区二区三区四区| 中出人妻视频一区二区| 男人舔奶头视频| 精品熟女少妇八av免费久了| 久久久久久免费高清国产稀缺| 日韩高清综合在线| 18禁观看日本| 午夜福利成人在线免费观看| 亚洲av美国av| 欧美高清成人免费视频www| 丝袜美腿诱惑在线| 色老头精品视频在线观看| 午夜福利视频1000在线观看| 国产av在哪里看| 日韩欧美在线二视频| 长腿黑丝高跟| 无限看片的www在线观看| 欧美成人一区二区免费高清观看 | 黄色视频不卡| 99国产精品一区二区三区| a在线观看视频网站| 国产三级中文精品| 法律面前人人平等表现在哪些方面| 波多野结衣高清作品| 91九色精品人成在线观看| a级毛片在线看网站| 日韩欧美 国产精品| 狂野欧美激情性xxxx| 在线永久观看黄色视频| 国产激情偷乱视频一区二区| 亚洲一码二码三码区别大吗| 久久婷婷成人综合色麻豆| 欧美3d第一页| 丰满人妻一区二区三区视频av | 免费在线观看成人毛片| 99久久精品热视频| 国产精品野战在线观看| 欧美在线一区亚洲| 两个人的视频大全免费| 欧美成人免费av一区二区三区| 欧美黑人欧美精品刺激| 搞女人的毛片| tocl精华| 美女大奶头视频| 国产在线精品亚洲第一网站| 91av网站免费观看| 国产精品久久久久久久电影 | 亚洲色图 男人天堂 中文字幕| 亚洲美女黄片视频| 黑人欧美特级aaaaaa片| 欧美日韩亚洲综合一区二区三区_| 久热爱精品视频在线9| 99久久国产精品久久久| 国产高清激情床上av| 窝窝影院91人妻| 欧美zozozo另类| 12—13女人毛片做爰片一| 特大巨黑吊av在线直播| 19禁男女啪啪无遮挡网站| 欧美激情久久久久久爽电影| 好男人在线观看高清免费视频| 国产在线观看jvid| 日韩大尺度精品在线看网址| 岛国在线免费视频观看| 三级国产精品欧美在线观看 | 天天一区二区日本电影三级| 好男人在线观看高清免费视频| 国产在线观看jvid| 免费在线观看日本一区| 大型av网站在线播放| 国产精品综合久久久久久久免费| 国产激情久久老熟女| 国产亚洲欧美在线一区二区| 国产精品免费视频内射| 欧美黑人精品巨大| 国产成人精品久久二区二区免费| 男女视频在线观看网站免费 | 美女扒开内裤让男人捅视频| 国产精品日韩av在线免费观看| 777久久人妻少妇嫩草av网站| 热99re8久久精品国产| 日本 av在线| 中文字幕高清在线视频| 这个男人来自地球电影免费观看| 欧美日本亚洲视频在线播放| 99热这里只有是精品50| 欧美成人性av电影在线观看| 免费在线观看影片大全网站| 亚洲精品国产一区二区精华液| av有码第一页| 久久国产精品影院| 最新在线观看一区二区三区| 亚洲18禁久久av| 又黄又爽又免费观看的视频| 狂野欧美白嫩少妇大欣赏| 国产精品久久久久久精品电影| 中文资源天堂在线| 青草久久国产| 国产又色又爽无遮挡免费看| 麻豆一二三区av精品| 免费看十八禁软件| 亚洲成人精品中文字幕电影| 国产探花在线观看一区二区| 欧美在线一区亚洲| 此物有八面人人有两片| 亚洲男人的天堂狠狠| 欧美一区二区国产精品久久精品 | 日本a在线网址| 黄色 视频免费看| 亚洲国产精品久久男人天堂| av在线天堂中文字幕| 亚洲一区二区三区色噜噜| 亚洲avbb在线观看| 久久久精品欧美日韩精品| 精品国产超薄肉色丝袜足j| 国产v大片淫在线免费观看| av有码第一页| 国产精品亚洲一级av第二区| 狂野欧美激情性xxxx| 女生性感内裤真人,穿戴方法视频| 精品福利观看| 成年免费大片在线观看| 亚洲精品美女久久av网站| 亚洲精品一卡2卡三卡4卡5卡| 国产亚洲欧美98| 亚洲成人国产一区在线观看| 成人高潮视频无遮挡免费网站| 无人区码免费观看不卡| 免费电影在线观看免费观看| 欧美性长视频在线观看| 国产成人一区二区三区免费视频网站| 国产精品,欧美在线| www日本在线高清视频| 黄色片一级片一级黄色片| 免费在线观看完整版高清| 天天一区二区日本电影三级| 无人区码免费观看不卡| 88av欧美| 亚洲一区中文字幕在线| 日本撒尿小便嘘嘘汇集6| 免费高清视频大片| 777久久人妻少妇嫩草av网站| 国产69精品久久久久777片 | 亚洲人与动物交配视频| 99热只有精品国产|